Dublin, Aug. 27, 2019 (GLOBE NEWSWIRE) -- The "Global Ventricular Assist Devices and Total Artificial Heart Market: Focus on Products, Distribution Channels, Regional, Data - Analysis and Forecast, 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The global ventricular assist devices and artificial heart systems market was estimated at $2.2 billion in 2018 and is anticipated to reach $2.7 billion by 2023. In 2018, ventricular assist devices contributed about 90% of market share.
Heart attack and stroke have resulted in the increasing mortality rate worldwide as per the World Health Organization (WHO). In 2016, it was estimated that about 17.9 million people died due to CVDs, which represented about 31% of the global mortality rate. Heart attack and stroke have contributed to the growing number of individuals suffering from CVDs. According to the WHO, stroke or cerebrovascular accident are the second leading cause of death worldwide.
The prevalence of heart failure has been estimated to increase during the recent years, due to the changing lifestyle, high levels of alcohol and tobacco consumption, and unhealthy diet plan. The ventricular assist devices and artificial heart systems are two key products used for mechanical circulatory support in end-stage heart failure patients. The market demand for these devices has emerged due to a lack of organ donors and high incidence of heart failure cases worldwide.
Expert Quote
North America is currently the leading contributor in the global ventricular assist devices and artificial heart systems market. The North America ventricular assist devices and artificial heart systems market was valued at $1.42 billion in 2018. Factors such as increasing incidence of heart failure cases, rise in aging population, pediatric heart failure cases, changing reimbursement policies, and established healthcare infrastructure are driving the growth of the ventricular assist devices and artificial heart systems market in North America.
Scope of the Market Intelligence
The purpose of the study is to gain a holistic view of the global ventricular assist devices and artificial heart systems market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the mechanical circulatory assist devices which have the potential to help the end-stage heart failure patients.
The global ventricular assist devices and artificial heart systems market is segmented into three types: product type, distribution channel, and region. The global market value was estimated using these three different approaches, which were validated with one another. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions.
Market Segmentation
The ventricular assist devices market is further sub-segmented into left-, right-, and bi-ventricular assist devices. The left-ventricular assist device segment contributed maximum to the product revenue contributing 60% of share in 2018. The product launches in the pipeline are expected to increase the CAGR of the market in the coming future.
Based on the distribution channel, hospitals occupied higher market share contributing more than 90% to the market revenue as of 2018. In 2018, cardiology clinics showed significant growth in the market with a CAGR of 4.19%, with the rising number of patient reference to these clinics by the VAD centers.
The global ventricular assist devices and artificial heart systems market is segmented by the geographical regions into North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW). The RoW region comprises Latin America, Middle East, and Africa.
North America is the leading contributor to the global ventricular assist devices and artificial heart systems market with a contribution of about 64.5% of the total market share in 2018. The North American market is also expected to grow at a CAGR of 3.26% in the forecast period 2019-2023.
The global ventricular assist devices and artificial heart systems market is majorly dominated by the U.S. and the European players. However, several emerging countries of Asia-Pacific and Latin America displayed a high potential to witness a robust growth rate during the period. The emerging countries have low access to the ventricular assist devices and artificial heart systems due to cost constraints in the market.
Key Companies
The key players who have significant contributions to the global ventricular assist devices and artificial heart systems market are Abbott Laboratories, Medtronic PLC, LivaNova PLC, Abiomed, SynCardia Systems, LLC, Jarvik Heart Inc., Berlin Heart, BiVACOR, among others.
Key Topics Covered
Executive Summary
1 Product Definition
1.1 Ventricular Assist Devices
1.2 Total Artificial Heart
2 Scope of the Report
3 Research Methodology
4 Industry Analysis
4.1 Industry Structure
4.2 Value Chain Analysis
4.3 Regulatory Framework
4.4 Patent Analysis
5 Competitive Landscape
5.1 Vendor Share Analysis
5.2 Key Developments and Strategies
5.2.1 Funding
5.2.2 Product Approvals
5.2.3 Mergers and Acquisitions
5.2.4 Agreements, Partnerships, and Collaborations
5.2.5 Other Strategies
6 Market Dynamics
6.1 Market Drivers
6.1.1 Growing Geriatric Population
6.1.2 Rising Incidence of Lifestyle Diseases
6.1.3 Increasing Need of Organ Transplantation and Deadly Shortage of Available Donors
6.1.4 Persistent Support from Government and Non-Governmental Organizations
6.1.5 Technological Advancements and Increased R&D Expenditure
6.2 Challenges
6.2.1 Risks of Device Malfunction and Other Related Concerns
6.2.2 Immune Barrier to Artificial Organ
6.2.3 Stringent Regulation and Poor Reimbursement Coverage
6.2.4 Exorbitant Cost of Product
6.3 Opportunities
6.3.1 Application of Advanced Biomaterials in Artificial Organs
6.3.2 Organ-on-chips Technology
7 Global Ventricular Assist Devices and Total Artificial Heart Market (Product)
7.1 Overview
7.2 Assumptions and Limitations
7.3 Ventricular Assist Devices
7.3.1 Components of a VAD
7.3.2 Types of VAD
7.3.3 Timeline
7.3.4 Left Ventricular Assist Device
7.3.5 Right Ventricular Assist Device
7.3.6 Bi-Ventricular Assist Device
7.4 Total Artificial Heart
7.4.1 Timeline
8 Global Ventricular Assist Devices and Total Artificial Heart Market (Distribution Channels)
8.1 Overview
8.2 Hospitals
8.3 Cardiology Clinics
9 Global Ventricular Assist Devices and Total Artificial Heart Market (by Region)
9.1 Overview
9.1.1 Analysis of Growth Potential of Different Countries
9.2 North America
9.2.1 The U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 The U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Sweden
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 Australia
9.4.4 India
9.5 Rest-of-the-World
9.5.1 Latin America
9.5.2 Middle East and Africa
10 Company Profiles
- Abbott Laboratories
- ABIOMED
- Berlin Heart
- BiVACOR
- CARMAT
- Jarvik Heart Inc.
- Sun Medical Technology Research Institute Inc.
- LivaNova PLC
- Medtronic PLC
- SynCardia Systems LLC
For more information about this report visit https://www.researchandmarkets.com/r/t696vt
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.